Safety Data Sheet

cause redness and irritation.
Ingestion
Specific test data for the substance or mixture is not available. Ingestion may
cause irritation to mucous membranes. Ingestion may cause gastrointestinal
irritation, nausea, vomiting and diarrhea.
Component Information
Information on toxicological
effects
Symptoms: Erythema (skin redness). May cause redness and tearing of the
eyes. Itching. Rashes. Hives.
Delayed and immediate
effects as well as chronic
effects from short and
long-term exposure
Sensitization: May cause sensitization of susceptible persons. May cause
sensitization by skin contact.
Mutagenic Effects: No information available.
Carcinogenicity: The table below indicates whether each agency has listed
any ingredient as a carcinogen
Chemical Name
ACGIH
IARC
NTP
OSHA
Lithium Cobalt
Oxide (CoLiO2)
12190-79-3
A3
Group 2B
X
ACGIH (American Conference of Governmental Industrial Hygienists)
A3 - Animal Carcinogen
IARC (International Agency for Research on Cancer)
Group 1 - Carcinogenic to Humans
Group 2B - Possibly Carcinogenic to Humans
Group 3 - Not Classifiable as to Carcinogenicity in Humans
OSHA (Occupational Safety and Health Administration of the US Department of Labor)
X – Present
Reproductive Toxicity
No information available.
STOT - single exposure
No information available.
STOT – repeated exposure
Causes damage to organs through prolonged or repeated exposure. Based
on classification criteria from the 2012 OSHA Hazard Communication
Standard (29 CFR 1910.1200), this product has been determined to cause
systemic target organ toxicity from chronic or repeated exposure. (STOT
RE).
Chronic Toxicity
Contains a known or suspected carcinogen. Avoid repeated exposure.
Prolonged exposure may cause chronic effects. May cause adverse liver
effects.
Target Organ Effects
Respiratory system. Eyes. Skin. Gastrointestinal tract (GI). Central Vascular
System (CVS).Kidney. Liver. Lungs. Heart.
Aspiration Hazard
No information available.
Numerical measures of toxicity Product Information
The values which are on the
right are calculated based on
chapter 3.1 of the GHS
document.
ATEmix (oral)
ATEmix (dermal)
ATEmix (inhalation-dust/mist)